 | • レポートコード：MRC2-11QY04404 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はシュードモナス診断検査のグローバル市場について調査・分析したレポートです。種類別（尿路感染症、皮膚炎、呼吸器系感染症、軟部組織感染症、胃腸感染症、骨関節感染症、心内膜炎、眼感染症）市場規模、用途別（商業/私立研究所、診療所、病院、公衆衛生研究所、学術研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別シュードモナス診断検査の競争状況、市場シェア ・世界のシュードモナス診断検査市場：種類別市場規模 2015年-2020年（尿路感染症、皮膚炎、呼吸器系感染症、軟部組織感染症、胃腸感染症、骨関節感染症、心内膜炎、眼感染症） ・世界のシュードモナス診断検査市場：種類別市場規模予測 2021年-2026年（尿路感染症、皮膚炎、呼吸器系感染症、軟部組織感染症、胃腸感染症、骨関節感染症、心内膜炎、眼感染症） ・世界のシュードモナス診断検査市場：用途別市場規模 2015年-2020年（商業/私立研究所、診療所、病院、公衆衛生研究所、学術研究所） ・世界のシュードモナス診断検査市場：用途別市場規模予測 2021年-2026年（商業/私立研究所、診療所、病院、公衆衛生研究所、学術研究所） ・北米のシュードモナス診断検査市場分析：米国、カナダ ・ヨーロッパのシュードモナス診断検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのシュードモナス診断検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のシュードモナス診断検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのシュードモナス診断検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Enzo Biochem、Beckman Coulter、FUJIFILM Wako Pure Chemical、Becton Dickinson、Ortho-Clinical Diagnostics、BioméRieux、Bio-Rad Laboratories、Thermo Fisher Scientific、Eiken Chemical、Siemens、Scienion、Roche、Cepheid、Olympus、Novartis、Johnson & Johnson ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Pseudomonas is a genus of Gram-negative, Gammaproteobacteria, belonging to the family Pseudomonadaceae and containing 191 validly described species.
The global pseudomonas diagnostic testing market is expected to grow rapidly over the forecast period owing to the advanced application of bacterial diagnostic instruments.
Market Analysis and Insights: Global Pseudomonas Diagnostic Testing Market
The global Pseudomonas Diagnostic Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pseudomonas Diagnostic Testing Scope and Market Size
Pseudomonas Diagnostic Testing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pseudomonas Diagnostic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Enzo Biochem
Beckman Coulter
FUJIFILM Wako Pure Chemical
Becton Dickinson
Ortho-Clinical Diagnostics
BioméRieux
Bio-Rad Laboratories
Thermo Fisher Scientific
Eiken Chemical
Siemens
Scienion
Roche
Cepheid
Olympus
Novartis
Johnson & Johnson
Market segment by Type, the product can be split into
Urinary Tract Infections
Dermatitis
Respiratory System Infections
Soft Tissue Infections
Gastrointestinal Infections
Bone and Joint Infections
Endocarditis
Eye Infection
Market segment by Application, split into
Commercial or Private Labs
Physician Offices
Hospitals
Public Health Labs
Academic Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Pseudomonas Diagnostic Testing Revenue
1.4 Market by Type
1.4.1 Global Pseudomonas Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Urinary Tract Infections
1.4.3 Dermatitis
1.4.4 Respiratory System Infections
1.4.5 Soft Tissue Infections
1.4.6 Gastrointestinal Infections
1.4.7 Bone and Joint Infections
1.4.8 Endocarditis
1.4.9 Eye Infection
1.5 Market by Application
1.5.1 Global Pseudomonas Diagnostic Testing Market Share by Application: 2020 VS 2026
1.5.2 Commercial or Private Labs
1.5.3 Physician Offices
1.5.4 Hospitals
1.5.5 Public Health Labs
1.5.6 Academic Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Pseudomonas Diagnostic Testing Market Perspective (2015-2026)
2.2 Global Pseudomonas Diagnostic Testing Growth Trends by Regions
2.2.1 Pseudomonas Diagnostic Testing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Pseudomonas Diagnostic Testing Historic Market Share by Regions (2015-2020)
2.2.3 Pseudomonas Diagnostic Testing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Pseudomonas Diagnostic Testing Market Growth Strategy
2.3.6 Primary Interviews with Key Pseudomonas Diagnostic Testing Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Pseudomonas Diagnostic Testing Players by Market Size
3.1.1 Global Top Pseudomonas Diagnostic Testing Players by Revenue (2015-2020)
3.1.2 Global Pseudomonas Diagnostic Testing Revenue Market Share by Players (2015-2020)
3.1.3 Global Pseudomonas Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Pseudomonas Diagnostic Testing Market Concentration Ratio
3.2.1 Global Pseudomonas Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Pseudomonas Diagnostic Testing Revenue in 2019
3.3 Pseudomonas Diagnostic Testing Key Players Head office and Area Served
3.4 Key Players Pseudomonas Diagnostic Testing Product Solution and Service
3.5 Date of Enter into Pseudomonas Diagnostic Testing Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pseudomonas Diagnostic Testing Historic Market Size by Type (2015-2020)
4.2 Global Pseudomonas Diagnostic Testing Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Pseudomonas Diagnostic Testing Market Size by Application (2015-2020)
5.2 Global Pseudomonas Diagnostic Testing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Pseudomonas Diagnostic Testing Market Size (2015-2020)
6.2 Pseudomonas Diagnostic Testing Key Players in North America (2019-2020)
6.3 North America Pseudomonas Diagnostic Testing Market Size by Type (2015-2020)
6.4 North America Pseudomonas Diagnostic Testing Market Size by Application (2015-2020)
7 Europe
7.1 Europe Pseudomonas Diagnostic Testing Market Size (2015-2020)
7.2 Pseudomonas Diagnostic Testing Key Players in Europe (2019-2020)
7.3 Europe Pseudomonas Diagnostic Testing Market Size by Type (2015-2020)
7.4 Europe Pseudomonas Diagnostic Testing Market Size by Application (2015-2020)
8 China
8.1 China Pseudomonas Diagnostic Testing Market Size (2015-2020)
8.2 Pseudomonas Diagnostic Testing Key Players in China (2019-2020)
8.3 China Pseudomonas Diagnostic Testing Market Size by Type (2015-2020)
8.4 China Pseudomonas Diagnostic Testing Market Size by Application (2015-2020)
9 Japan
9.1 Japan Pseudomonas Diagnostic Testing Market Size (2015-2020)
9.2 Pseudomonas Diagnostic Testing Key Players in Japan (2019-2020)
9.3 Japan Pseudomonas Diagnostic Testing Market Size by Type (2015-2020)
9.4 Japan Pseudomonas Diagnostic Testing Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Pseudomonas Diagnostic Testing Market Size (2015-2020)
10.2 Pseudomonas Diagnostic Testing Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Pseudomonas Diagnostic Testing Market Size by Type (2015-2020)
10.4 Southeast Asia Pseudomonas Diagnostic Testing Market Size by Application (2015-2020)
11 India
11.1 India Pseudomonas Diagnostic Testing Market Size (2015-2020)
11.2 Pseudomonas Diagnostic Testing Key Players in India (2019-2020)
11.3 India Pseudomonas Diagnostic Testing Market Size by Type (2015-2020)
11.4 India Pseudomonas Diagnostic Testing Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Pseudomonas Diagnostic Testing Market Size (2015-2020)
12.2 Pseudomonas Diagnostic Testing Key Players in Central & South America (2019-2020)
12.3 Central & South America Pseudomonas Diagnostic Testing Market Size by Type (2015-2020)
12.4 Central & South America Pseudomonas Diagnostic Testing Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Pseudomonas Diagnostic Testing Introduction
13.1.4 Abbott Laboratories Revenue in Pseudomonas Diagnostic Testing Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Enzo Biochem
13.2.1 Enzo Biochem Company Details
13.2.2 Enzo Biochem Business Overview
13.2.3 Enzo Biochem Pseudomonas Diagnostic Testing Introduction
13.2.4 Enzo Biochem Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.2.5 Enzo Biochem Recent Development
13.3 Beckman Coulter
13.3.1 Beckman Coulter Company Details
13.3.2 Beckman Coulter Business Overview
13.3.3 Beckman Coulter Pseudomonas Diagnostic Testing Introduction
13.3.4 Beckman Coulter Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.3.5 Beckman Coulter Recent Development
13.4 FUJIFILM Wako Pure Chemical
13.4.1 FUJIFILM Wako Pure Chemical Company Details
13.4.2 FUJIFILM Wako Pure Chemical Business Overview
13.4.3 FUJIFILM Wako Pure Chemical Pseudomonas Diagnostic Testing Introduction
13.4.4 FUJIFILM Wako Pure Chemical Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.4.5 FUJIFILM Wako Pure Chemical Recent Development
13.5 Becton Dickinson
13.5.1 Becton Dickinson Company Details
13.5.2 Becton Dickinson Business Overview
13.5.3 Becton Dickinson Pseudomonas Diagnostic Testing Introduction
13.5.4 Becton Dickinson Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.5.5 Becton Dickinson Recent Development
13.6 Ortho-Clinical Diagnostics
13.6.1 Ortho-Clinical Diagnostics Company Details
13.6.2 Ortho-Clinical Diagnostics Business Overview
13.6.3 Ortho-Clinical Diagnostics Pseudomonas Diagnostic Testing Introduction
13.6.4 Ortho-Clinical Diagnostics Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.6.5 Ortho-Clinical Diagnostics Recent Development
13.7 BioméRieux
13.7.1 BioméRieux Company Details
13.7.2 BioméRieux Business Overview
13.7.3 BioméRieux Pseudomonas Diagnostic Testing Introduction
13.7.4 BioméRieux Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.7.5 BioméRieux Recent Development
13.8 Bio-Rad Laboratories
13.8.1 Bio-Rad Laboratories Company Details
13.8.2 Bio-Rad Laboratories Business Overview
13.8.3 Bio-Rad Laboratories Pseudomonas Diagnostic Testing Introduction
13.8.4 Bio-Rad Laboratories Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.8.5 Bio-Rad Laboratories Recent Development
13.9 Thermo Fisher Scientific
13.9.1 Thermo Fisher Scientific Company Details
13.9.2 Thermo Fisher Scientific Business Overview
13.9.3 Thermo Fisher Scientific Pseudomonas Diagnostic Testing Introduction
13.9.4 Thermo Fisher Scientific Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.9.5 Thermo Fisher Scientific Recent Development
13.10 Eiken Chemical
13.10.1 Eiken Chemical Company Details
13.10.2 Eiken Chemical Business Overview
13.10.3 Eiken Chemical Pseudomonas Diagnostic Testing Introduction
13.10.4 Eiken Chemical Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
13.10.5 Eiken Chemical Recent Development
13.11 Siemens
10.11.1 Siemens Company Details
10.11.2 Siemens Business Overview
10.11.3 Siemens Pseudomonas Diagnostic Testing Introduction
10.11.4 Siemens Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
10.11.5 Siemens Recent Development
13.12 Scienion
10.12.1 Scienion Company Details
10.12.2 Scienion Business Overview
10.12.3 Scienion Pseudomonas Diagnostic Testing Introduction
10.12.4 Scienion Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
10.12.5 Scienion Recent Development
13.13 Roche
10.13.1 Roche Company Details
10.13.2 Roche Business Overview
10.13.3 Roche Pseudomonas Diagnostic Testing Introduction
10.13.4 Roche Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
10.13.5 Roche Recent Development
13.14 Cepheid
10.14.1 Cepheid Company Details
10.14.2 Cepheid Business Overview
10.14.3 Cepheid Pseudomonas Diagnostic Testing Introduction
10.14.4 Cepheid Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
10.14.5 Cepheid Recent Development
13.15 Olympus
10.15.1 Olympus Company Details
10.15.2 Olympus Business Overview
10.15.3 Olympus Pseudomonas Diagnostic Testing Introduction
10.15.4 Olympus Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
10.15.5 Olympus Recent Development
13.16 Novartis
10.16.1 Novartis Company Details
10.16.2 Novartis Business Overview
10.16.3 Novartis Pseudomonas Diagnostic Testing Introduction
10.16.4 Novartis Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
10.16.5 Novartis Recent Development
13.17 Johnson & Johnson
10.17.1 Johnson & Johnson Company Details
10.17.2 Johnson & Johnson Business Overview
10.17.3 Johnson & Johnson Pseudomonas Diagnostic Testing Introduction
10.17.4 Johnson & Johnson Revenue in Pseudomonas Diagnostic Testing Business (2015-2020)
10.17.5 Johnson & Johnson Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Pseudomonas Diagnostic Testing Key Market Segments
Table 2. Key Players Covered: Ranking by Pseudomonas Diagnostic Testing Revenue
Table 3. Ranking of Global Top Pseudomonas Diagnostic Testing Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Pseudomonas Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Urinary Tract Infections
Table 6. Key Players of Dermatitis
Table 7. Key Players of Respiratory System Infections
Table 8. Key Players of Soft Tissue Infections
Table 9. Key Players of Gastrointestinal Infections
Table 10. Key Players of Bone and Joint Infections
Table 11. Key Players of Endocarditis
Table 12. Key Players of Eye Infection
Table 13. Global Pseudomonas Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Pseudomonas Diagnostic Testing Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Pseudomonas Diagnostic Testing Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Pseudomonas Diagnostic Testing Market Share by Regions (2015-2020)
Table 17. Global Pseudomonas Diagnostic Testing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Pseudomonas Diagnostic Testing Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Pseudomonas Diagnostic Testing Market Growth Strategy
Table 23. Main Points Interviewed from Key Pseudomonas Diagnostic Testing Players
Table 24. Global Pseudomonas Diagnostic Testing Revenue by Players (2015-2020) (Million US$)
Table 25. Global Pseudomonas Diagnostic Testing Market Share by Players (2015-2020)
Table 26. Global Top Pseudomonas Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudomonas Diagnostic Testing as of 2019)
Table 27. Global Pseudomonas Diagnostic Testing by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Pseudomonas Diagnostic Testing Product Solution and Service
Table 30. Date of Enter into Pseudomonas Diagnostic Testing Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Pseudomonas Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 33. Global Pseudomonas Diagnostic Testing Market Size Share by Type (2015-2020)
Table 34. Global Pseudomonas Diagnostic Testing Revenue Market Share by Type (2021-2026)
Table 35. Global Pseudomonas Diagnostic Testing Market Size Share by Application (2015-2020)
Table 36. Global Pseudomonas Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 37. Global Pseudomonas Diagnostic Testing Market Size Share by Application (2021-2026)
Table 38. North America Key Players Pseudomonas Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Pseudomonas Diagnostic Testing Market Share (2019-2020)
Table 40. North America Pseudomonas Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 41. North America Pseudomonas Diagnostic Testing Market Share by Type (2015-2020)
Table 42. North America Pseudomonas Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 43. North America Pseudomonas Diagnostic Testing Market Share by Application (2015-2020)
Table 44. Europe Key Players Pseudomonas Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Pseudomonas Diagnostic Testing Market Share (2019-2020)
Table 46. Europe Pseudomonas Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Pseudomonas Diagnostic Testing Market Share by Type (2015-2020)
Table 48. Europe Pseudomonas Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Pseudomonas Diagnostic Testing Market Share by Application (2015-2020)
Table 50. China Key Players Pseudomonas Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 51. China Key Players Pseudomonas Diagnostic Testing Market Share (2019-2020)
Table 52. China Pseudomonas Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 53. China Pseudomonas Diagnostic Testing Market Share by Type (2015-2020)
Table 54. China Pseudomonas Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 55. China Pseudomonas Diagnostic Testing Market Share by Application (2015-2020)
Table 56. Japan Key Players Pseudomonas Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Pseudomonas Diagnostic Testing Market Share (2019-2020)
Table 58. Japan Pseudomonas Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Pseudomonas Diagnostic Testing Market Share by Type (2015-2020)
Table 60. Japan Pseudomonas Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Pseudomonas Diagnostic Testing Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Pseudomonas Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Pseudomonas Diagnostic Testing Market Share (2019-2020)
Table 64. Southeast Asia Pseudomonas Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Pseudomonas Diagnostic Testing Market Share by Type (2015-2020)
Table 66. Southeast Asia Pseudomonas Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Pseudomonas Diagnostic Testing Market Share by Application (2015-2020)
Table 68. India Key Players Pseudomonas Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 69. India Key Players Pseudomonas Diagnostic Testing Market Share (2019-2020)
Table 70. India Pseudomonas Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 71. India Pseudomonas Diagnostic Testing Market Share by Type (2015-2020)
Table 72. India Pseudomonas Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 73. India Pseudomonas Diagnostic Testing Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Pseudomonas Diagnostic Testing Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Pseudomonas Diagnostic Testing Market Share (2019-2020)
Table 76. Central & South America Pseudomonas Diagnostic Testing Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Pseudomonas Diagnostic Testing Market Share by Type (2015-2020)
Table 78. Central & South America Pseudomonas Diagnostic Testing Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Pseudomonas Diagnostic Testing Market Share by Application (2015-2020)
Table 80. Abbott Laboratories Company Details
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Product
Table 83. Abbott Laboratories Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 84. Abbott Laboratories Recent Development
Table 85. Enzo Biochem Company Details
Table 86. Enzo Biochem Business Overview
Table 87. Enzo Biochem Product
Table 88. Enzo Biochem Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 89. Enzo Biochem Recent Development
Table 90. Beckman Coulter Company Details
Table 91. Beckman Coulter Business Overview
Table 92. Beckman Coulter Product
Table 93. Beckman Coulter Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 94. Beckman Coulter Recent Development
Table 95. FUJIFILM Wako Pure Chemical Company Details
Table 96. FUJIFILM Wako Pure Chemical Business Overview
Table 97. FUJIFILM Wako Pure Chemical Product
Table 98. FUJIFILM Wako Pure Chemical Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 99. FUJIFILM Wako Pure Chemical Recent Development
Table 100. Becton Dickinson Company Details
Table 101. Becton Dickinson Business Overview
Table 102. Becton Dickinson Product
Table 103. Becton Dickinson Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 104. Becton Dickinson Recent Development
Table 105. Ortho-Clinical Diagnostics Company Details
Table 106. Ortho-Clinical Diagnostics Business Overview
Table 107. Ortho-Clinical Diagnostics Product
Table 108. Ortho-Clinical Diagnostics Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 109. Ortho-Clinical Diagnostics Recent Development
Table 110. BioméRieux Company Details
Table 111. BioméRieux Business Overview
Table 112. BioméRieux Product
Table 113. BioméRieux Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 114. BioméRieux Recent Development
Table 115. Bio-Rad Laboratories Business Overview
Table 116. Bio-Rad Laboratories Product
Table 117. Bio-Rad Laboratories Company Details
Table 118. Bio-Rad Laboratories Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 119. Bio-Rad Laboratories Recent Development
Table 120. Thermo Fisher Scientific Company Details
Table 121. Thermo Fisher Scientific Business Overview
Table 122. Thermo Fisher Scientific Product
Table 123. Thermo Fisher Scientific Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 124. Thermo Fisher Scientific Recent Development
Table 125. Eiken Chemical Company Details
Table 126. Eiken Chemical Business Overview
Table 127. Eiken Chemical Product
Table 128. Eiken Chemical Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 129. Eiken Chemical Recent Development
Table 130. Siemens Company Details
Table 131. Siemens Business Overview
Table 132. Siemens Product
Table 133. Siemens Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 134. Siemens Recent Development
Table 135. Scienion Company Details
Table 136. Scienion Business Overview
Table 137. Scienion Product
Table 138. Scienion Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 139. Scienion Recent Development
Table 140. Roche Company Details
Table 141. Roche Business Overview
Table 142. Roche Product
Table 143. Roche Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 144. Roche Recent Development
Table 145. Cepheid Company Details
Table 146. Cepheid Business Overview
Table 147. Cepheid Product
Table 148. Cepheid Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 149. Cepheid Recent Development
Table 150. Olympus Company Details
Table 151. Olympus Business Overview
Table 152. Olympus Product
Table 153. Olympus Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 154. Olympus Recent Development
Table 155. Novartis Company Details
Table 156. Novartis Business Overview
Table 157. Novartis Product
Table 158. Novartis Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 159. Novartis Recent Development
Table 160. Johnson & Johnson Company Details
Table 161. Johnson & Johnson Business Overview
Table 162. Johnson & Johnson Product
Table 163. Johnson & Johnson Revenue in Pseudomonas Diagnostic Testing Business (2015-2020) (Million US$)
Table 164. Johnson & Johnson Recent Development
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pseudomonas Diagnostic Testing Market Share by Type: 2020 VS 2026
Figure 2. Urinary Tract Infections Features
Figure 3. Dermatitis Features
Figure 4. Respiratory System Infections Features
Figure 5. Soft Tissue Infections Features
Figure 6. Gastrointestinal Infections Features
Figure 7. Bone and Joint Infections Features
Figure 8. Endocarditis Features
Figure 9. Eye Infection Features
Figure 10. Global Pseudomonas Diagnostic Testing Market Share by Application: 2020 VS 2026
Figure 11. Commercial or Private Labs Case Studies
Figure 12. Physician Offices Case Studies
Figure 13. Hospitals Case Studies
Figure 14. Public Health Labs Case Studies
Figure 15. Academic Research Institutes Case Studies
Figure 16. Pseudomonas Diagnostic Testing Report Years Considered
Figure 17. Global Pseudomonas Diagnostic Testing Market Size YoY Growth 2015-2026 (US$ Million)
Figure 18. Global Pseudomonas Diagnostic Testing Market Share by Regions: 2020 VS 2026
Figure 19. Global Pseudomonas Diagnostic Testing Market Share by Regions (2021-2026)
Figure 20. Porter's Five Forces Analysis
Figure 21. Global Pseudomonas Diagnostic Testing Market Share by Players in 2019
Figure 22. Global Top Pseudomonas Diagnostic Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudomonas Diagnostic Testing as of 2019
Figure 23. The Top 10 and 5 Players Market Share by Pseudomonas Diagnostic Testing Revenue in 2019
Figure 24. North America Pseudomonas Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Europe Pseudomonas Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. China Pseudomonas Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Japan Pseudomonas Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Southeast Asia Pseudomonas Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. India Pseudomonas Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Central & South America Pseudomonas Diagnostic Testing Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
耐性緑膿菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Resistant Pseudomonas Aeruginosa Infections Drugs Market The global Resistant Pseudomonas Aeruginosa Infections Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Resistant Pseud…- 医療関連感染（HAI）診断の世界市場（～2026年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…
- 人工関節感染症治療の世界市場（～2026年） Market Analysis and Insights: Global Prosthetic Joint Infections Treatment Market The global Prosthetic Joint Infections Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prosthetic Joint Infections Treatment S…
- 病院治療グラム陰性菌感染症の世界市場（～2026年） Gram-negative bacteria are non-pathogenic in person with the normal immune system. However, in person with a weak immune system having gram negative bacteria can behave as significant pathogens. The ability to prevent the effect of such micro-organisms is significantly hampered by the resistance of …
- 感染性胃腸炎検査の世界市場（～2026年） Gastrointestinal infection is the most common type of infection encountered in patient populations. These infections are not always severe but they often resolve rapidly on their own without any treatment. Growing adoption of technologically advanced molecular techniques and rising incidence of gast…